Healthcare Equipment and Supplies
Company Overview of Magellan Diagnostics, Inc.
Magellan Diagnostics, Inc., a medical device company, develops and manufactures point-of-care systems, clinical laboratory instruments, and analytical laboratory services focused on lead testing. Its products include LeadCare, a CLIA-waived device to test for lead exposure at the point of care. The company also provides various analytical services, such as lead and heavy metal exposure, monitoring exposure in employees, and testing. It offers its LeadCare for use by pediatricians and nurses in the United States, as well as Departments of Public health; women, infants, and children clinics; and head start programs. Magellan Diagnostics, Inc. was formerly known as Magellan Biosciences, Inc. Th...
101 Billerica Avenue
North Billerica, MA 01862
Founded in 2004
Key Executives for Magellan Diagnostics, Inc.
Chief Financial Officer and Vice President of Operations & Supply Chain
Chief Operating Officer and President of ESA Biosciences
President of Trek Diagnostic Systems
Compensation as of Fiscal Year 2014.
Magellan Diagnostics, Inc. Key Developments
Magellan Diagnostics Receives FDA Clearance for LeadCare Ultra Bench-Top Clinical Lead Analyzer
Aug 26 13
Magellan Diagnostics, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the LeadCare Ultra Blood Lead Testing System in the US for the quantification of lead levels in blood. LeadCare Ultra is the "plug-and-play" solution for laboratory lead analysis. It brings a significant improvement in the speed and cost of lead testing while providing labs the first bench-top lead testing system with an easy-to-use and flexible design. The LeadCare Ultra System is based on technology developed by Magellan Diagnostics that has been in clinical use for nearly two decades and that is currently helping over 5,000 clinicians rapidly test and identify individuals who suffer from lead exposure.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries